Accretion Nutrav

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1KVQ01019
  • NSEID:
  • BSEID: 544694
INR
201.00
-1.15 (-0.57%)
BSENSE

Apr 10

BSE+NSE Vol: 14000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

14.0 k (-7.89%) Volume

Shareholding (Feb 2026)

FII

6.04%

Held by 1 FIIs

DII

6.51%

Held by 0 DIIs

Promoter

73.48%

Why is Accretion Nutraveda Ltd falling/rising?

08-Apr-2026

As of 07-Apr, Accretion Nutraveda Ltd's stock price is at 198.00, unchanged from the previous day, but has declined 4.78% over the past week. The stock has underperformed its sector and benchmark, with a recent loss of 2.43% today and decreased investor participation.

As of 07-Apr, Accretion Nutraveda Ltd's stock price is currently at 198.00, showing no change from the previous day. However, the stock has been experiencing a downward trend, having fallen consecutively for the last three days, resulting in a total decline of 4.78% over the past week. This performance is notably worse than the benchmark Sensex, which has increased by 3.71% during the same period.<BR><BR>Today, the stock opened with a loss of 2.43% and reached an intraday low of Rs 193.55, reflecting a decrease of 4.16%. Additionally, the stock has underperformed its sector by 2.33% today. There has also been a decline in investor participation, with delivery volume dropping by 1.64% compared to the five-day average. Despite these negative indicators, it is worth noting that the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests some underlying strength in the longer-term trend.<BR><BR>Overall, the combination of recent consecutive losses, poor performance relative to the sector and benchmark, and declining investor participation are contributing to the current downward movement in the stock price of Accretion Nutraveda Ltd.

View full answer

Why is Accretion Nutraveda Ltd falling/rising?

09-Apr-2026

As of 08-Apr, Accretion Nutraveda Ltd's stock price is at Rs 209.50, up 5.81%, supported by strong sector performance and positive moving averages. However, there is a notable decline in investor participation, with delivery volume down 57.14% from the 5-day average.

As of 08-Apr, Accretion Nutraveda Ltd's stock price is rising, currently at Rs 209.50, reflecting an increase of Rs 11.5 or 5.81%. This upward movement is supported by several factors. The stock has outperformed its sector by 4.96% today and opened with a gain of 3.56%. Additionally, it has reached an intraday high of Rs 209.5, indicating strong buying interest.<BR><BR>Moreover, Accretion Nutraveda Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a positive trend in its price performance over various time frames. However, it is important to note that there has been a decline in investor participation, with delivery volume dropping by 57.14% compared to the 5-day average. Despite this decrease in participation, the stock remains liquid enough for trading.<BR><BR>Overall, the combination of a significant price increase today, strong performance relative to the sector, and favorable moving averages contribute to the rising stock price of Accretion Nutraveda Ltd.

View full answer

Why is Accretion Nutraveda Ltd falling/rising?

10-Apr-2026

As of 09-Apr, Accretion Nutraveda Ltd's stock price is at 203.00, down 0.56%, underperforming against the Sensex which rose by 4.52% over the past week. Despite a monthly gain of 9.14%, today's decline is influenced by erratic trading patterns and unfavorable market sentiment.

As of 09-Apr, Accretion Nutraveda Ltd's stock price is currently at 203.00, reflecting a decrease of 1.15 (-0.56%). The stock has underperformed compared to the benchmark Sensex, which has risen by 4.52% over the past week. Despite a positive performance of +9.14% over the past month, the stock's current decline can be attributed to its performance today, where it touched an intraday low of Rs 200, marking a decrease of 2.03%. <BR><BR>Additionally, the stock is experiencing erratic trading, having not traded on one day out of the last 20 days, which may contribute to its volatility. While it is trading above its moving averages for various periods, indicating some strength, the overall market sentiment appears to be unfavorable today, leading to the observed decline. Furthermore, although there has been a rise in investor participation with a 23.08% increase in delivery volume against the 5-day average, this has not been sufficient to counteract the downward pressure on the stock price.

View full answer

Which are the latest news on Accretion Nutrav?

10-Apr-2026
No latest news for Accretion Nutrav found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 145 Cr (Micro Cap)

stock-summary
P/E

56.00

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

04-Apr-2026 | Source : BSE

Please find enclosed herewith intimation under regulation 74(5) of SEBI (DP) Regulations 2018

Intimation For Change Of Corporate Identification Number (CIN) Of The Company.

01-Apr-2026 | Source : BSE

Pursuant to the listing of Equity share of the Company the Corporate Identification Number (CIN) in the Master Data as available on the Ministry of Corporate Affairs (MCA) portal has been updated.

Closure of Trading Window

28-Mar-2026 | Source : BSE

Please find enclosed herewith intimation w.r.t Closure of Trading Window

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
2.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
17.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.54%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
56
Industry P/E
32
Price to Book Value
NA
EV to EBIT
41.82
EV to EBITDA
39.12
EV to Capital Employed
NA
EV to Sales
9.10
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
NA
ROE (Latest)
NA

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
No Trend
OBV
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Feb 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (6.04%)

Promoter with highest holding

Ankurkumar Shantilal Patel (14.7%)

Highest Public shareholder

Unicorn Fund (6.51%)

Individual Investors Holdings

10.48%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Accretion Nutrav"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Accretion Nutrav"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Accretion Nutrav"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Accretion Nutrav"
  }
]
stock-summaryCompany CV
About Accretion Nutraveda Ltd stock-summary
stock-summary
Accretion Nutraveda Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Accretion Nutraveda Limited was initially incorporated as a Private Limited Company on March 16, 2021 and has subsequently, converted the status into a Public Limited Company vide Certificate of Incorporation issued by the Registrar of Companies, Central Processing Centre w.e.f. May 2, 2025.
Company Coordinates stock-summary
Icon
No Company Details Available